10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-054427`
Period End Date	20200331
Filing Date	20200430
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	enzn-20200331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 22 Cash Flow Statement 19 Stockholders Equity 11

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$5.14M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$485.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$970.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$123.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$62.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.24M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.99M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	-	USD	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$485.00K	USD	Point-in-time
Total assets	`Assets`	$6.48M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$6.24M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$324.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$322.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$102.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$99.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$424.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$423.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at March 31, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at March 31, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at March 31, 2020 and December 31, 2019	`CommonStockValue`	$442.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at March 31, 2020 and December 31, 2019	`CommonStockValue`	$442.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$75.69M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$75.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.08M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.05M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.48M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.24M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Royalties, net	`RoyaltyRevenueAndMilestones`	$-51.00K	USD	1 Quarter
Royalties, net	`RoyaltyRevenueAndMilestones`	$2.00K	USD	1 Quarter
Total revenues	`Revenues`	$2.00K	USD	1 Quarter
Total revenues	`Revenues`	$-51.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$242.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$318.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$242.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$318.00K	USD	1 Quarter
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-240.00K	USD	1 Quarter
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-369.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-242.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-371.00K	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,215.00	shares	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,215.00	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,215.00	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,215.00	shares	1 Quarter

Cash Flow Statement 19 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-371.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-242.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-82.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$60.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-302.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-289.00K	USD	1 Quarter
Common stock dividends	`PaymentsOfDividendsCommonStock`	$2.65B	USD	Point-in-time
Common stock dividends	`PaymentsOfDividendsCommonStock`	$2.65M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.65M	USD	1 Quarter
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-302.00K	USD	1 Quarter
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.94M	USD	1 Quarter
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.14M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.45M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.56M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.14M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.45M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.56M	USD	Point-in-time

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$6.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.97M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.81M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-242.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-371.00K	USD	1 Quarter
Common stock dividend	`DividendsCommonStockStock`	$2.65M	USD	1 Quarter
Balance	`StockholdersEquity`	$6.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.97M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.81M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.